Sturamustine
Clinical data | |
---|---|
Synonyms | N-(2-Chloroethyl)-N'-(3-hydroxyandrost-5-en-17-yl)-N-nitrosourea |
Identifiers | |
| |
CAS Number | |
ChemSpider | |
Chemical and physical data | |
Formula | C22H34ClN3O3 |
Molar mass | 423.982 g/mol |
3D model (JSmol) | |
| |
|
Sturamustine, also known as dehydroepiandrosterone (DHEA) 17β-N-(2-chloroethyl)-N-nitrosourea, is a synthetic androstane steroid and a C17β nitrosourea conjugate of dehydroepiandrosterone (DHEA) that was developed as an alkylating antineoplastic agent (i.e., a chemotherapy drug) for the treatment of hormone-dependent tumors but was never marketed.[1][2] It was synthesized in 1982.[1][2]
See also
- Alestramustine
- Atrimustine
- Cytestrol acetate
- Estradiol mustard
- Estramustine phosphate
- LS-1727
- Prednimustine
- Testifenon
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.